Arkolith/Insider Trading/CGTX/Form 4

Doyle John Brendan

Chief Financial OfficerCOGNITION THERAPEUTICS INC (CGTX) · full profile →Form 4 · filed Dec 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Tax withholding(F)9K$1.50$14K446K
Dec 18, 2025Grant(A)30K—$0455K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-123721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML